HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTFA Annual Meeting In Brief: CTFA Board members

This article was originally published in The Rose Sheet

Executive Summary

CTFA Board members: Bristol-Myers Squibb Worldwide Beauty Care President Steven Sadove re-elected to another one-year term as Chairman of the Cosmetic, Toiletry and Fragrance Association board at the trade group's annual meeting Feb. 28-March 2 in Boca Raton, Fla. Also returning to CTFA's board are three Vice Chairman -- Johnson & Johnson Group Franchise Chairman, Consumer Products Worldwide William Egan; Merle Norman Cosmetics Chairman J.B. Nethercutt; and Cosmair President and CEO Guy Peyrelongue. Maybelline Chairman Robert Hiatt will continue to serve as treasurer and Elysee Scientific Cosmetics President Linda Marshall will continue her duties as secretary. The board also named Dana Perfumes/Renaissance Cosmetics CEO Tom Bonoma to fill an active member vacancy...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003874

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel